Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Buttar

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Chemical Science|October 27, 2022
Machine learning meets mechanistic modelling for accurate prediction of experimental activation energiesKjell Jorner, Tore Brinck, Per-Ola Norrby, et al.
Physical Chemistry Chemical Physics : PCCP|August 3, 2018
Solubility prediction from first principles: a density of states approachSimon Boothroyd, Andy Kerridge, Anders Broo, et al.
Molecular Informatics|July 29, 2016
Automated QSAR with a Hierarchy of Global and Local ModelsDavid J Wood, David Buttar, John G Cumming, et al.
Journal of Chemical Information and Modeling|March 28, 2006
Scaffold hopping using clique detection applied to reduced graphsEdward J Barker, David Buttar, David A Cosgrove, et al.
Bioorganic & Medicinal Chemistry|September 28, 2010
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactionsDavid Buttar, Nicola Colclough, Stefan Gerhardt, et al.
The Journal of Organic Chemistry|October 15, 2021
Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRAS<sup>G12C</sup> InhibitorJames J Douglas, Matthew R Tatton, Daniël de Bruin, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2008
Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailableDavid Buttar, Mike Edge, Steve C Emery, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivoRichard W A Luke, Peter Ballard, David Buttar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitorM Raymond V Finlay, David Buttar, Susan E Critchlow, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Chemical Science|October 27, 2022
Machine learning meets mechanistic modelling for accurate prediction of experimental activation energiesKjell Jorner, Tore Brinck, Per-Ola Norrby, et al.
Physical Chemistry Chemical Physics : PCCP|August 3, 2018
Solubility prediction from first principles: a density of states approachSimon Boothroyd, Andy Kerridge, Anders Broo, et al.
Molecular Informatics|July 29, 2016
Automated QSAR with a Hierarchy of Global and Local ModelsDavid J Wood, David Buttar, John G Cumming, et al.
Journal of Chemical Information and Modeling|March 28, 2006
Scaffold hopping using clique detection applied to reduced graphsEdward J Barker, David Buttar, David A Cosgrove, et al.
Bioorganic & Medicinal Chemistry|September 28, 2010
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactionsDavid Buttar, Nicola Colclough, Stefan Gerhardt, et al.
The Journal of Organic Chemistry|October 15, 2021
Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRAS<sup>G12C</sup> InhibitorJames J Douglas, Matthew R Tatton, Daniël de Bruin, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2008
Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailableDavid Buttar, Mike Edge, Steve C Emery, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivoRichard W A Luke, Peter Ballard, David Buttar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitorM Raymond V Finlay, David Buttar, Susan E Critchlow, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Pageof 2